Teva Pharmaceutical Industries Ltd (TEVA)

31.13
NYSE : Health Care
Prev Close 30.76
Day Low/High 30.80 / 31.21
52 Wk Low/High 30.57 / 57.52
Avg Volume 9.24M
Exchange NYSE
Shares Outstanding 1.01B
Market Cap 31.22B
EPS 0.10
P/E Ratio 5.98
Div & Yield 1.36 (4.40%)

Latest News

Teva Launches AirDuo™ RespiClick® And Its Authorized Generic, Two Inhalers Containing Fluticasone Propionate And Salmeterol

Teva Launches AirDuo™ RespiClick® And Its Authorized Generic, Two Inhalers Containing Fluticasone Propionate And Salmeterol

Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced the simultaneous launch of AirDuo ™ RespiClick ® (fluticasone propionate and salmeterol) inhalation powder and its authorized generic for...

Teva Showcases CNS Portfolio At 69th Annual Meeting Of The American Academy Of Neurology

Teva Showcases CNS Portfolio At 69th Annual Meeting Of The American Academy Of Neurology

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced data for five of the Company's innovative therapies for central nervous system (CNS) disorders will be presented at the 69 th Annual Meeting of the...

We've Stepped Into Panicky Territory, but Don't Panic

We will be oversold enough to have a rally this coming week.

2 Biotech Pullback Targets

2 Biotech Pullback Targets

Acadia and Neurocrine both have catalysts for growth; buy any weakness.

Neurocrine Biosciences Snags U.S. Approval for Movement Disorder Drug

Neurocrine Biosciences Snags U.S. Approval for Movement Disorder Drug

The U.S. Food and Drug Administration granted Ingrezza a relatively clean label that does not include a black box safety warning against suicidality or depression.

Allergan and Celgene Are in Peak Health

Allergan and Celgene Are in Peak Health

These stocks should be part of a strong first-quarter earnings season.

Teva Pharmaceutical Said to Be Exploring Sale of Women's Health Unit

Teva Pharmaceutical Said to Be Exploring Sale of Women's Health Unit

Teva Pharmaceutical's women's health business could sell for $2 billion.

Teva To Report First Quarter 2017 Financial Results On May 11, 2017

Teva To Report First Quarter 2017 Financial Results On May 11, 2017

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its first quarter 2017 financial results on Thursday, May 11, 2017 at 7:00 a.

Mylan Has Been Pounded, but the Pain May be Far from Over

Mylan Has Been Pounded, but the Pain May be Far from Over

The maker of the EpiPen seems incapable of overcoming its troubles.

Teva Pharmaceutical Receives FDA Approval For Huntington's Drug

Teva Pharmaceutical Receives FDA Approval For Huntington's Drug

Austedo is the second drug to be approved for the treatment of chorea.

Teva Announces FDA Approval Of AUSTEDO™ (deutetrabenazine) Tablets For The Treatment Of Chorea Associated With Huntington's Disease

Teva Announces FDA Approval Of AUSTEDO™ (deutetrabenazine) Tablets For The Treatment Of Chorea Associated With Huntington's Disease

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.

Teva Pharmaceutical Looks Vulnerable to Further Losses

Teva Pharmaceutical Looks Vulnerable to Further Losses

It will probably take a close above $38 to turn the chart more bullish.

Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen

Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen

The Roche drug, Ocrevus, secured FDA approval for two forms of multiple sclerosis.

End of Health-Care Bill Could Be a Win for Markets: Cramer's 'Mad Money' Recap (Friday 3/24/17)

End of Health-Care Bill Could Be a Win for Markets: Cramer's 'Mad Money' Recap (Friday 3/24/17)

Look ahead, Jim Cramer says. This might be a good time to buy industrials, financials, FANG, and tech opportunities.

Teva Pharmaceuticals, Sirius XM Radio, Marriott International: 'Mad Money' Lightning Round

Teva Pharmaceuticals, Sirius XM Radio, Marriott International: 'Mad Money' Lightning Round

Jim Cramer is bullish on Sirius XM Radio, Kratos Defense and Security, and Marriott International.

Teva Announces Launch Of Authorized Generic Of Minastrin® 24 Fe (norethindrone Acetate And Ethinyl Estradiol Tablets And Ferrous Fumarate Tablets) In The United States

Teva Announces Launch Of Authorized Generic Of Minastrin® 24 Fe (norethindrone Acetate And Ethinyl Estradiol Tablets And Ferrous Fumarate Tablets) In The United States

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of the Authorized Generic of Minastrin ® 24 Fe 1 (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) 1...

Teva To Present At The Barclays Global Annual Healthcare Conference

Teva To Present At The Barclays Global Annual Healthcare Conference

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Barclays Global Healthcare Conference in Miami, Florida.

Why Battered Biotech Teva Is a Smart Contrarian Buy Right Now

Why Battered Biotech Teva Is a Smart Contrarian Buy Right Now

A firestorm in Washington has created a fire sale for shares of this undervalued stock.

Sorry, the Correction Isn't Over

Why aren't people more concerned?

Teva To Present At The Cowen & Company 37th Annual Healthcare Conference

Teva To Present At The Cowen & Company 37th Annual Healthcare Conference

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Cowen & Company 37 th Annual Healthcare Conference in Boston, MA.

Mylan's Governance May Be the Root of Its Problems

Mylan's Governance May Be the Root of Its Problems

The scandals plaguing the pharmaceutical company can be traced to lack of change at the board level.

Twenty More States Accuse Mylan, Teva and Others of Price Collusion

Twenty More States Accuse Mylan, Teva and Others of Price Collusion

Forty states have now sued the companies.

Teva Announces Launch Of Generic Pristiq® In The United States

Teva Announces Launch Of Generic Pristiq® In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic Pristiq ®1 (desvenlafaxine) extended-release tablets, 25, 50 and 100 mg, in the U.

Teva Announces Priority Review Granted By FDA For SD-809 For Treatment Of Tardive Dyskinesia

Teva Announces Priority Review Granted By FDA For SD-809 For Treatment Of Tardive Dyskinesia

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced the U.

Go With Allergan, Celgene and 'Big Mo'

Go With Allergan, Celgene and 'Big Mo'

These two large-cap drug giants should be core parts of any well-diversified portfolio.

Teva Files 2016 Annual Report On Form 20-F

Teva Files 2016 Annual Report On Form 20-F

In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, Teva Pharmaceutical Industries Ltd.

5 Ways Allergan Can Keep Up Momentum

5 Ways Allergan Can Keep Up Momentum

Allergan's most-recent quarterly financial report for Q4/2016 showed solid results.

Closing Bell: Apple Rallies to New Highs; U.S. Stocks End at Fresh Records for Day Three

Closing Bell: Apple Rallies to New Highs; U.S. Stocks End at Fresh Records for Day Three

Wall Street rallies to new records as leftover goodwill from Friday's rally pushes stocks to new heights.